Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer (scientific article published on 24 July 2019)

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

Q33332312

Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data

Q33366370

MRI quantification of non-Gaussian water diffusion by kurtosis analysis

Q33633190

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

Q33739695

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Q34121226

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

Q34729698

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

Q34959906

Rethinking ovarian cancer: recommendations for improving outcomes

Q36050883

Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging

Q36088325

Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation

Q36561792

Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis

Q37276915

Making the best of PARP inhibitors in ovarian cancer

Q37779240

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer

Q37840389

Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors

Q38457423

Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer

Q38517581

Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation

Q38663402

Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity

Q40297984

Taxol (paclitaxel): mechanisms of action

Q40598848

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

Q40673230

Modern techniques in radiological imaging related to oncology.

Q40689186

A method for mapping and quantifying whole organ diffusion-weighted image distortion in MR imaging of the prostate

Q42149311

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

Q42216907

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

Q43280969

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

Q44461877

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

Q46799385

Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients

Q48201834

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

Q48276582

Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.

Q53175270

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

Q53963245

Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients

Q56748718

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

Q71079779

Relationship between bone marrow cellularity and apparent diffusion coefficient

Q73820550

Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma

Q77323351

Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer

Q81352965

A cytohistological study of Ki-67 expression in ovarian tumors

Q83585639

The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancer

Q87154726

Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression

Q89508687

Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis

Q90840685

P433

issue

P921

main subject

ovarian cancer

Q172341

biomarker

Q864574

P304

page(s)

10742

P577

publication date

2019-07-24

P1433

published in

Scientific Reports

Q2261792

P1476

title

Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer

P478

volume